Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douketis

Showing results (241-250 of 314) with videos related to

Pageof 32
Sort By:
The Cochrane Database of Systematic Reviews|April 25, 2018
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolismSusan R Kahn, David R Morrison, Gisèle Diendéré, et al.
Archives of Internal Medicine|May 26, 1997
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosisJ S Ginsberg, C Kearon, J Douketis, et al.
Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Circulation|June 16, 2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trialJeff S Healey, John Eikelboom, James Douketis, et al.
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
The Canadian Journal of Cardiology|August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapyJean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
Journal of Clinical Medicine|October 27, 2022
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical TrialsKonstantinos G Kyriakoulis, Evangelos Dimakakos, Ioannis G Kyriakoulis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 3, 2022
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbentRitu Tripathi, Jesus Morales, Victoria Lee, et al.
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
American Journal of Hematology|April 5, 2012
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz, Peter A Kouides, David A Garcia, et al.
Pageof 32

Showing results (241-250 of 314) with videos related to

Sort By:
Pageof 32
The Cochrane Database of Systematic Reviews|April 25, 2018
Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolismSusan R Kahn, David R Morrison, Gisèle Diendéré, et al.
Archives of Internal Medicine|May 26, 1997
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosisJ S Ginsberg, C Kearon, J Douketis, et al.
Thrombosis and Haemostasis|December 5, 2014
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
Circulation|June 16, 2012
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trialJeff S Healey, John Eikelboom, James Douketis, et al.
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.
The Canadian Journal of Cardiology|August 28, 2013
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapyJean-François Tanguay, Alan D Bell, Margaret L Ackman, et al.
Journal of Clinical Medicine|October 27, 2022
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical TrialsKonstantinos G Kyriakoulis, Evangelos Dimakakos, Ioannis G Kyriakoulis, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|June 3, 2022
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbentRitu Tripathi, Jesus Morales, Victoria Lee, et al.
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
American Journal of Hematology|April 5, 2012
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz, Peter A Kouides, David A Garcia, et al.
Pageof 32